Psilocybin and Music Genre: Emotional Effects in Healthy Adults
A 2026 placebo-controlled study reveals that both psilocybin and the choice of musical genre independently shape emotional responses to music, offering new insights for clinical trial design and therapeutic protocols.
Psilocybin and Musical Genre Independently Shape Emotional Responses
Psilocybin and the specific genre of music played during psychedelic sessions each independently influence the emotional responses of healthy adult volunteers, according to a double-blind, placebo-controlled study published on September 23, 2026 (OpenAlex W7214115953). The research, conducted in two parts with a total of 36 participants, systematically evaluated how different musical compositions and psilocybin administration affect music-evoked emotions, using validated scales for affective valence and emotional dimensions.
The study's design included a pilot phase (n=19) to screen various genres—ranging from Rock/Punk to Classical/Baroque and Electronic/Psytrance—followed by a focused assessment (n=17) using the Geneva Emotional Music Scale (GEMS-9) for two contrasting compositions: one classical and one psytrance. Oral psilocybin was administered at 0.26 mg/kg, with sessions timed to the plateau phase of the drug's effect, ensuring consistency in the emotional assessment window.
Mechanisms: How Psilocybin and Music Genre Modulate Affect
Psilocybin increases feelings of wonder, transcendence, and joyful activation in response to music, regardless of genre, as measured by participant self-report during the plateau phase. The classical composition was associated with greater peacefulness, tenderness, and nostalgia, while the psytrance composition elicited higher tension across both psilocybin and placebo conditions. Notably, a significant interaction emerged for sadness: under psilocybin, sadness increased during the classical piece but decreased during the psytrance track.
This pattern suggests that while psilocybin broadly amplifies certain positive emotional states, the specific emotional profile evoked by music is still strongly shaped by the genre and composition. The limited interaction effects between drug and music type indicate that set (drug state) and setting (musical environment) may be optimized separately in protocol design, rather than relying on a uniform emotional amplification across all musical choices.
Implications for Clinical Trials and Therapeutic Protocols
Music selection is a critical, yet often underappreciated, variable in psychedelic-assisted therapy and research protocols. The findings from this study provide empirical support for the strategic tailoring of musical environments to desired therapeutic outcomes or research endpoints. For trial designers, the data suggest that genre and composition should be pre-specified and justified as part of the protocol, especially when emotional outcomes are primary or secondary endpoints.
For clinicians, the evidence that classical and electronic/psytrance genres evoke distinct emotional profiles under psilocybin highlights the need for intentional music curation. For example, classical music may be preferable for fostering peacefulness and nostalgia, while electronic genres may be better suited for activating or energizing sessions. Importantly, the nuanced finding that psilocybin can increase sadness in response to certain music challenges the assumption that all emotional effects are uniformly positive or therapeutic, emphasizing the need for careful monitoring and support.
Risks, Unknowns, and Limitations
The primary risks associated with music selection in psychedelic settings relate to the potential for unintended or overwhelming emotional responses, including increased sadness or tension, as observed in this study. The sample size (n=36) limits generalizability, and the study was conducted in healthy volunteers rather than clinical populations, so implications for patients with depression, anxiety, or trauma remain speculative.
Another limitation is the reliance on self-report measures, which, while validated, may not capture the full complexity of music-evoked affect under altered states of consciousness. The study did not assess longer-term outcomes or therapeutic efficacy, and the interaction between individual music preferences and drug effects remains an open question. Researchers and clinicians should also consider cultural and demographic factors that may mediate both musical preference and emotional response.
Looking Forward: Optimizing Set and Setting in Psychedelic Research
The independent and composition-specific effects of psilocybin and music genre on emotional responses underscore the importance of protocol customization in psychedelic research and therapy. Future studies should explore larger and more diverse samples, include clinical populations, and consider integrating physiological or neuroimaging measures to complement self-report data.
For stakeholders designing trials or therapeutic programs, this research provides a new decision criterion: the emotional profile of music should be matched to session goals, and the potential for adverse or unexpected affective responses should be explicitly managed. As the field moves toward regulatory approval and broader clinical adoption, such granular insights into set and setting variables will be essential for maximizing benefit and minimizing risk.
Reviewed by Dr. Alex M. Reiss, PhD (Neuroscience), on 2026-09-25. Research based on primary data from the referenced OpenAlex study and direct review of methodological details.
Get tomorrow's briefing in your inbox
Policy, research, and regulatory signal — delivered on our publish cadence.